Official Journal of the Human Genome Organisation
From: The impact of cis-acting polymorphisms on the human phenotype
Gene | Variant | Effect | Phenotype/disease risk | Methods to show function | Reference(s) |
---|---|---|---|---|---|
ADH1B | C>A rs1229982 in proximal promoter | Increases promoter activity 1.4 fold | Associated with alcoholism | Transfections | Pochareddy and Edenberg (2011) |
DARC | T-46C | Impairs promoter activity | Resistance to malaria | Transfections | Tournamille et al. (1995) |
FMO3 | Promoter haplotypes (1 kb) | ‘2’ 8 fold increase in activity, ‘8’ & ‘15’ loss of activity | ‘8’ & ‘15’ may contribute to trimethylaminuria | Transfections | Koukouritaki et al. (2005) |
IL6 | Promoter haplotype variation | Altered IL6 expression | Various disease associations | Transfections | Terry et al. (2000) |
IL10 | Promoter haplotype variation | TA2 haplotype has higher levels of IL10 expression | High risk TA2 haplotype associated with trachoma susceptibility | AE | Natividad et al. (2008) |
IL13 | C-1055T | T increases IL13 expression | Association with asthma & allergy | Gel shift assay | van der Pouw Kraan et al. (1999) |
LCT | Several in enhancer ~14Â kb upstream within MCM6 | Higher expression of lactase in adulthood | Lactase persistence into adult life | Transfections & gel shift assay | See Ingram et al. (2009a) |
LTC 4 S | A-444C | Altered expression | Linked to aspirin associated asthma & chronic hyperplastic eosinophilic sinusitis | AE | de Alarcon et al. (2006) |
MUC5B | Several promoter haplotypes | Altered MUC5B expression | Underrepresentation of low expression haplotypes in patients with diffuse panbronchiolitis | AE & transfections | |
OCA2 | Rs12913832 (21,152Â bp upstream within HERC2) | Derived allele lowers promoter activity | Associated with blue eye colour in homozygotes | Transfections & gel shift assays | Eiberg et al. (2008) |
SHH | Several mutations 1mb upstream in enhancer within LMBR1 (& in other species) | Altered TF binding | Preaxial polydactyly | Gel shift assay & transgenic assay in mice | |
UGT1A1 | (TA)n repeat in TATA box | (TA)7 (low expression) | Gilberts syndrome, adverse drug reactions | Transfections | Bosma et al. (1995) |
UGT2B15 | Promoter haplotypes (rs34010522 & rs35513228) | Altered expression | Possible links to oxazepam glucuronidation, breast and prostate cancer risk | Transfections | Sun et al. (2010) |